241 related articles for article (PubMed ID: 26438600)
1. Lysine Acetylation of CREBH Regulates Fasting-Induced Hepatic Lipid Metabolism.
Kim H; Mendez R; Chen X; Fang D; Zhang K
Mol Cell Biol; 2015 Dec; 35(24):4121-34. PubMed ID: 26438600
[TBL] [Abstract][Full Text] [Related]
2. CREBH Maintains Circadian Glucose Homeostasis by Regulating Hepatic Glycogenolysis and Gluconeogenesis.
Kim H; Zheng Z; Walker PD; Kapatos G; Zhang K
Mol Cell Biol; 2017 Jul; 37(14):. PubMed ID: 28461393
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-induced acetylation of Foxa2 regulates hepatic lipid metabolism.
von Meyenn F; Porstmann T; Gasser E; Selevsek N; Schmidt A; Aebersold R; Stoffel M
Cell Metab; 2013 Mar; 17(3):436-47. PubMed ID: 23416070
[TBL] [Abstract][Full Text] [Related]
4. Liver-enriched transcription factor CREBH interacts with peroxisome proliferator-activated receptor α to regulate metabolic hormone FGF21.
Kim H; Mendez R; Zheng Z; Chang L; Cai J; Zhang R; Zhang K
Endocrinology; 2014 Mar; 155(3):769-82. PubMed ID: 24424044
[TBL] [Abstract][Full Text] [Related]
5. CREBH Couples Circadian Clock With Hepatic Lipid Metabolism.
Zheng Z; Kim H; Qiu Y; Chen X; Mendez R; Dandekar A; Zhang X; Zhang C; Liu AC; Yin L; Lin JD; Walker PD; Kapatos G; Zhang K
Diabetes; 2016 Nov; 65(11):3369-3383. PubMed ID: 27507854
[TBL] [Abstract][Full Text] [Related]
6. Glucagon regulates hepatic lipid metabolism via cAMP and Insig-2 signaling: implication for the pathogenesis of hypertriglyceridemia and hepatic steatosis.
Wang H; Zhao M; Sud N; Christian P; Shen J; Song Y; Pashaj A; Zhang K; Carr T; Su Q
Sci Rep; 2016 Sep; 6():32246. PubMed ID: 27582413
[TBL] [Abstract][Full Text] [Related]
7. Regulation of hepatic autophagy by stress-sensing transcription factor CREBH.
Kim H; Williams D; Qiu Y; Song Z; Yang Z; Kimler V; Goldberg A; Zhang R; Yang Z; Chen X; Wang L; Fang D; Lin JD; Zhang K
FASEB J; 2019 Jul; 33(7):7896-7914. PubMed ID: 30912978
[TBL] [Abstract][Full Text] [Related]
8. Inducible hepatic expression of CREBH mitigates diet-induced obesity, insulin resistance, and hepatic steatosis in mice.
Krumm CS; Xu X; Bare CJ; Holman CD; Kersten S; Dow LE; Lee AH; Cohen DE
J Biol Chem; 2021 Jul; 297(1):100815. PubMed ID: 34023388
[TBL] [Abstract][Full Text] [Related]
9. CREBH Regulates Systemic Glucose and Lipid Metabolism.
Nakagawa Y; Shimano H
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29738435
[TBL] [Abstract][Full Text] [Related]
10. MS-275 induces hepatic FGF21 expression via H3K18ac-mediated CREBH signal.
Zhang Q; Zhu Q; Deng R; Zhou F; Zhang L; Wang S; Zhu K; Wang X; Zhou L; Su Q
J Mol Endocrinol; 2019 May; 62(4):187-196. PubMed ID: 30893641
[TBL] [Abstract][Full Text] [Related]
11. The liver-enriched transcription factor CREBH is nutritionally regulated and activated by fatty acids and PPARalpha.
Danno H; Ishii KA; Nakagawa Y; Mikami M; Yamamoto T; Yabe S; Furusawa M; Kumadaki S; Watanabe K; Shimizu H; Matsuzaka T; Kobayashi K; Takahashi A; Yatoh S; Suzuki H; Yamada N; Shimano H
Biochem Biophys Res Commun; 2010 Jan; 391(2):1222-7. PubMed ID: 20006574
[TBL] [Abstract][Full Text] [Related]
12. Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice.
Zhang C; Wang G; Zheng Z; Maddipati KR; Zhang X; Dyson G; Williams P; Duncan SA; Kaufman RJ; Zhang K
Hepatology; 2012 Apr; 55(4):1070-82. PubMed ID: 22095841
[TBL] [Abstract][Full Text] [Related]
13. The Role and Mechanism of CREBH Regulating SIRT3 in Metabolic Associated Fatty Liver Disease.
Junli Z; Shuhan W; Yajuan Z; Xiaoling D; Jiahuan L; Keshu X
Life Sci; 2022 Oct; 306():120838. PubMed ID: 35902030
[TBL] [Abstract][Full Text] [Related]
14. Regulation of hepatic circadian metabolism by the E3 ubiquitin ligase HRD1-controlled CREBH/PPARα transcriptional program.
Kim H; Wei J; Song Z; Mottillo E; Samavati L; Zhang R; Li L; Chen X; Jena BP; Lin JD; Fang D; Zhang K
Mol Metab; 2021 Jul; 49():101192. PubMed ID: 33592335
[TBL] [Abstract][Full Text] [Related]
15. N-glycosylation of CREBH improves lipid metabolism and attenuates lipotoxicity in NAFLD by modulating PPARα and SCD-1.
Zhang N; Wang Y; Zhang J; Liu B; Deng X; Xin S; Xu K
FASEB J; 2020 Nov; 34(11):15338-15363. PubMed ID: 32996649
[TBL] [Abstract][Full Text] [Related]
16. Hepatic Aryl Hydrocarbon Receptor Attenuates Fibroblast Growth Factor 21 Expression.
Girer NG; Murray IA; Omiecinski CJ; Perdew GH
J Biol Chem; 2016 Jul; 291(29):15378-87. PubMed ID: 27226639
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptor type 1 (CB1R) signaling regulates hepatic gluconeogenesis via induction of endoplasmic reticulum-bound transcription factor cAMP-responsive element-binding protein H (CREBH) in primary hepatocytes.
Chanda D; Kim DK; Li T; Kim YH; Koo SH; Lee CH; Chiang JY; Choi HS
J Biol Chem; 2011 Aug; 286(32):27971-9. PubMed ID: 21693703
[TBL] [Abstract][Full Text] [Related]
18. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange.
Liu Y; Dentin R; Chen D; Hedrick S; Ravnskjaer K; Schenk S; Milne J; Meyers DJ; Cole P; Yates J; Olefsky J; Guarente L; Montminy M
Nature; 2008 Nov; 456(7219):269-73. PubMed ID: 18849969
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional activation of Fsp27 by the liver-enriched transcription factor CREBH promotes lipid droplet growth and hepatic steatosis.
Xu X; Park JG; So JS; Lee AH
Hepatology; 2015 Mar; 61(3):857-69. PubMed ID: 25125366
[TBL] [Abstract][Full Text] [Related]
20. Activation of cannabinoid receptor type 1 (Cb1r) disrupts hepatic insulin receptor signaling via cyclic AMP-response element-binding protein H (Crebh)-mediated induction of Lipin1 gene.
Chanda D; Kim YH; Kim DK; Lee MW; Lee SY; Park TS; Koo SH; Lee CH; Choi HS
J Biol Chem; 2012 Nov; 287(45):38041-9. PubMed ID: 22989885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
